Gene: CLBA1

122616
C14orf79
clathrin binding box of aftiphilin containing 1
protein-coding
14q32.33
Ensembl:ENSG00000140104 Vega:OTTHUMG00000170474 UniprotKB:Q96F83
NC_000014.9
SNP Mapped
1   ANCO-SNPs
AD
0   
NA (AD)  NA (ND)   (Frontal_Cortex)
5.718e-1 (AD)  1.518e-1 (ND)

ANCO-SNPs

SNP ID Position Alleles Trait Variation Type
rs10133292chr14:104990824 (GRCh38.p7)T>Calcohol dependenceSNV(Single Nucleotide Variation)

DNA Methylation

There is no related methylation information for this gene.

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Drugs/Compounds

    There is no DrugBank record for this gene !

ID Drug Name Action PubMed
C1111182',3,3',4',5-pentachloro-4-hydroxybiphenyl"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of CLBA1 mRNA"19114083
D000082AcetaminophenAcetaminophen results in decreased expression of CLBA1 mRNA26690555
D016604Aflatoxin B1Aflatoxin B1 results in increased expression of CLBA1 mRNA21641981|2210060
D001280AtrazineAtrazine results in decreased expression of CLBA1 mRNA22378314
D001564Benzo(a)pyreneBenzo(a)pyrene results in decreased expression of CLBA1 mRNA22316170
C006780bisphenol Abisphenol A results in decreased expression of CLBA1 mRNA25181051
C000611646bisphenol F[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CLBA1 mRNA28628672
C584509C646 compoundC646 compound results in increased expression of CLBA1 mRNA26191083
D003907Dexamethasone[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CLBA1 mRNA28628672
D003993Dibutyl PhthalateDibutyl Phthalate results in decreased expression of CLBA1 mRNA21266533
D019422Dietary SucroseDietary Sucrose results in increased expression of CLBA1 mRNA26033743
C492448ICG 001ICG 001 results in decreased expression of CLBA1 mRNA26191083
D007213Indomethacin[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CLBA1 mRNA28628672
D0150561-Methyl-3-isobutylxanthine[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CLBA1 mRNA28628672
D008741Methyl MethanesulfonateMethyl Methanesulfonate results in increased expression of CLBA1 mRNA23649840
C017947sodium arsenitesodium arsenite results in decreased expression of CLBA1 mRNA25879800
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin affects the expression of CLBA1 mRNA22298810
D014520UrethaneUrethane results in decreased expression of CLBA1 mRNA28818685
D014635Valproic AcidValproic Acid results in increased methylation of CLBA1 gene29154799

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO:0030276clathrin binding-IBA21873635  
GO ID GO Term Qualifier Evidence PubMed
GO:0046907intracellular transport-IBA21873635  
GO ID GO Term Qualifier Evidence PubMed
GO:0005737cytoplasm-IBA21873635  
KEGG ID KEGG Term
Reactome ID Reactome Term Evidence

Interactions (STRING v10.5, Interaction Score >= 0.400)

There is no Interaction data for this gene.

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal